Day & Ennis’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $645K | Hold |
1,215
| – | – | 0.23% | 72 |
|
|
2023
Q3 | $615K | Hold |
1,215
| – | – | 0.23% | 70 |
|
|
2023
Q2 | $634K | Hold |
1,215
| – | – | 0.24% | 65 |
|
|
2023
Q1 | $700K | Hold |
1,215
| – | – | 0.26% | 67 |
|
|
2022
Q4 | $669K | Buy |
1,215
+53
| +5% | +$28.1K | 0.26% | 67 |
|
|
2022
Q3 | $589K | Hold |
1,162
| – | – | 0.25% | 63 |
|
|
2022
Q2 | $631K | Hold |
1,162
| – | – | 0.24% | 64 |
|
|
2022
Q1 | $686K | Hold |
1,162
| – | – | 0.23% | 62 |
|
|
2021
Q4 | $775K | Hold |
1,162
| – | – | 0.25% | 58 |
|
|
2021
Q3 | $664K | Hold |
1,162
| – | – | 0.23% | 61 |
|
|
2021
Q2 | $586K | Hold |
1,162
| – | – | 0.2% | 63 |
|
|
2021
Q1 | $530K | Hold |
1,162
| – | – | 0.2% | 68 |
|
|
2020
Q4 | $541K | Sell |
1,162
-7
| -0.6% | -$3.28K | 0.21% | 61 |
|
|
2020
Q3 | $516K | Buy |
1,169
+7
| +0.6% | +$2.89K | 0.22% | 61 |
|
|
2020
Q2 | $421K | Hold |
1,162
| – | – | 0.21% | 65 |
|
|
2020
Q1 | $330K | Sell |
1,162
-753
| -39% | -$237K | 0.19% | 61 |
|
|
2019
Q4 | $622K | Hold |
1,915
| – | – | 0.3% | 53 |
|
|
2019
Q3 | $558K | Hold |
1,915
| – | – | 0.29% | 56 |
|
|
2019
Q2 | $562K | Hold |
1,915
| – | – | 0.3% | 54 |
|
|
2019
Q1 | $524K | Hold |
1,915
| – | – | 0.29% | 52 |
|
|
2018
Q4 | $429K | Sell |
1,915
-11
| -0.6% | -$2.58K | 0.28% | 57 |
|
|
2018
Q3 | $470K | Buy |
1,926
+2
| +0.1% | +$460 | 0.32% | 53 |
|
|
2018
Q2 | $399K | Buy |
1,924
+9
| +0.5% | +$1.91K | 0.3% | 57 |
|
|
2018
Q1 | $395K | Hold |
1,915
| – | – | 0.32% | 54 |
|
|
2017
Q4 | $364K | Hold |
1,915
| – | – | 0.3% | 56 |
|
|
2017
Q3 | $362K | Hold |
1,915
| – | – | 0.32% | 49 |
|
|
2017
Q2 | $334K | Sell |
1,915
-41
| -2% | -$6.89K | 0.29% | 58 |
|
|
2017
Q1 | $300K | Sell |
1,956
-14
| -0.7% | -$2.14K | 0.28% | 61 |
|
|
2016
Q4 | $278K | Buy |
1,970
+53
| +3% | +$7.81K | 0.28% | 52 |
|
|
2016
Q3 | $305K | Buy |
1,917
+34
| +2% | +$5.24K | 0.32% | 43 |
|
|
2016
Q2 | $278K | Hold |
1,883
| – | – | 0.3% | 46 |
|
|
2016
Q1 | $267K | Hold |
1,883
| – | – | 0.3% | 47 |
|
|
2015
Q4 | $267K | Buy |
+1,883
| New | +$251K | 0.3% | 48 |
|
Other funds holding TMO
Day & Ennis's TMO Position: Q4 2023 in Review
Day & Ennis held its Thermo Fisher Scientific (TMO) position steady in Q4 2023 at 1,215 shares worth $645K. The position accounts for 0.23% of the portfolio, ranked #72.
Day & Ennis first reported a position in TMO in Q4 2015 and has held it in 33 quarters since. The position peaked at $775K in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Day & Ennis held 1,215 shares of Thermo Fisher Scientific worth $645K as of Q4 2023.
- Day & Ennis left its Thermo Fisher Scientific share count unchanged in Q4 2023.
- Thermo Fisher Scientific made up 0.23% of Day & Ennis's portfolio in Q4 2023, its #72 holding.
- Day & Ennis first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 33 quarters since.
- Day & Ennis's Thermo Fisher Scientific position peaked at $775K in Q4 2021.
- 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.